Approval Year
| Substance Class |
Structurally Diverse
Created
by
admin
on
Edited
Sat Dec 16 18:27:01 GMT 2023
by
admin
on
Sat Dec 16 18:27:01 GMT 2023
|
| Source Materials Class | ORGANISM |
| Source Materials Type | AUTOLOGOUS HUMAN |
| Source Materials State | LIVE |
| Source Materials Parent | |
| Part | BLOOD |
| Fraction Material Type | CELL |
| Fraction Name | T CELLS |
| Record UNII |
8KCU7VN8MH
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
8KCU7VN8MH
Created by
admin on Sat Dec 16 18:27:01 GMT 2023 , Edited by admin on Sat Dec 16 18:27:01 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
CD3+/CD8+ cytotoxic T cells recognize pathogens or tumor antigens. These cells activated, they kill infected pathogen or tumor cells (reduce postsurgical recurrence rates of hepatocellular carcinoma)
|
Agent Modifications
| Modification Process | Modification Role | Modification Type | Amount | Fragment Name | Fragment ID |
|---|---|---|---|---|---|
| CULTURE | STIMULATION OF ATL | IMMUNOLOGICAL | HUMAN INTERLEUKIN-2 | FNO32LO217 | |
| CULTURE | PROMOTING ACTIVATION AND EXPANSION OF T CELLS | IMMUNOLOGICAL | MUROMONAB-CD3 | JGA39ICE2V |